English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community
Patient Daily | Feb 8, 2026

CDMOs look to FDA's PreCheck program for support at new US production sites

Patient Daily | Feb 8, 2026

Penn Medicine earns national recognition for top clinical research achievements

Patient Daily | Feb 8, 2026

ACAAI offers guidance for an allergy-safe Valentine’s Day

Patient Daily | Feb 8, 2026

HonorHealth Research Institute administers new investigational stroke drug as part of national trial

Patient Daily | Feb 8, 2026

Study links long-term air pollution exposure with higher ALS risk

Patient Daily | Feb 8, 2026

Global Virus Network urges action amid rising measles cases worldwide

Patient Daily | Feb 8, 2026

Blocking brain immune cells prevents early-life memory loss in mice

Patient Daily | Feb 8, 2026

Bio-detection dogs identify scent signature of aggressive canine cancer

Trending

+ Regulatory
Patient Daily | Apr 28, 2026

Archo Advocacy CEO Toresco on PBMs: 'PBMs profit from keeping prices high. Patients pay the spread'

+ Pharmaceuticals
Patient Daily | Apr 24, 2026

Washington Post Opinion Editor on 340B drug discounts: 'The program has become a profit-making venture for big businesses'

+ Regulatory
Patient Daily | Apr 29, 2026

USC Schaeffer Center's Sood on PBMs: 'If PBMs want to claim they save employers and patients billions, they should be willing to prove it'

+ Regulatory
Patient Daily | Apr 24, 2026

Steve Forbes on 340B program: Hospitals use it ‘to divert taxpayer-subsidized benefits for patients to unrelated interests’

  • « First
  • «
  • …
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily